Iveric bio downgraded to Neutral from Outperform at Credit Suisse
PremiumThe FlyIveric bio downgraded to Neutral from Outperform at Credit Suisse
2y ago
Guggenheim downgrades Iveric bio after deal, doesn’t expect other bidders
Premium
The Fly
Guggenheim downgrades Iveric bio after deal, doesn’t expect other bidders
2y ago
Iveric bio downgraded to Equal Weight from Overweight at Morgan Stanley
Premium
The Fly
Iveric bio downgraded to Equal Weight from Overweight at Morgan Stanley
2y ago
Iveric Bio (NASDAQ:ISEE) Sold for $5.9B
PremiumMarket NewsIveric Bio (NASDAQ:ISEE) Sold for $5.9B
2y ago
Astellas to acquire Iveric Bio for $40 per share in cash
Premium
The Fly
Astellas to acquire Iveric Bio for $40 per share in cash
2y ago
IVERIC bio call volume above normal and directionally bullish
Premium
The Fly
IVERIC bio call volume above normal and directionally bullish
2y ago
Stifel biopharmaceuticals analyst to hold an analyst/industry conference call
PremiumThe FlyStifel biopharmaceuticals analyst to hold an analyst/industry conference call
2y ago
Iveric bio price target raised to $19 from $17 at B. Riley
Premium
The Fly
Iveric bio price target raised to $19 from $17 at B. Riley
2y ago
Apellis rally on approval ‘might fade,’ says Wells Fargo
Premium
The Fly
Apellis rally on approval ‘might fade,’ says Wells Fargo
2y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100